1,223 research outputs found

    Author response: India and China in Africa: a comparative perspective of the oil industry by Raj Verma

    No full text
    Earlier this month Ian Taylor reviewed India and China in Africa, a new book about Asian engagement in the West African oil industry. Here, the book’s author Raj Verma responds to Taylor’s comments, outlining the rationale and evidence for the framework used in the study. India and China in Africa: A comparative perspective of the oil industry. Raj Verma. London: Routledge. 2017

    Protineuria in CKD Patient on Hemodialysis

    No full text
    Proteinuria is a distinguishing feature in primary and secondary forms of chronic glomerulonephritis, which contribute to no more than the 20 of the end stage kidney disease ESKD population. The contribution of non proteinuric nephropathies to the global ESKD burden is still poorly focused and scarce research efforts are dedicated to the elucidation of risk factors and mechanistic pathways triggering ESKD in these diseases. We abstracted information on proteinuria in the main renal diseases other than glomerulonephritides that may evolve into ESKD. In type 2 diabetes, non proteinuric diabetic kidney disease DKD is more frequent than proteinuric DKD, and risk factors for non proteinuric forms of DKD now receive increasing attention. Similarly, proteinuria is most often inconspicuous or absent in the most frequent cause of ESKD, i.e. hypertension related chronic kidney disease CKD , as well as in progressive cystic diseases like autosomal dominant polycystic kidney disease and in pyelonephritis tubulo interstitial diseases. Maintaining a high degree of attention in the care of CKD patients with proteinuria is fundamental to effectively retard progression toward kidney failure. However, substantial research efforts are still needed to develop treatment strategies that may help the vast majority of CKD patients who eventually develop ESKD via mechanistic pathways other than proteinuria. Atul Verma | Hulsi Sahu | Hemin Sahu "Protineuria in CKD Patient on Hemodialysis" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-4 , June 2018, URL: https://www.ijtsrd.com/papers/ijtsrd14602.pd

    Anemia in CKD Patient on Heamodialysis

    No full text
    Anemia in chronic kidney disease is a prevalent and expensive problem in the United States, and it is well documented that anemia worsens as glomerular filtration rates decline. The complications of severe anemia in this patient population contribute significantly to their overall morbidity with increased cardiovascular complications, decreased quality of life, and increased dependence on transfusions to maintain adequate hemoglobin levels. Erythropoietin stimulating agents ESAs have revolutionized the treatment of anemia in this population, but there has been a great deal of controversy surrounding the quest for the ideal hemoglobin target. In addition, there are economic and practice management implications where anemia treatment is concerned, with ongoing refinement of Centers for Medicare and Medicaid Services bundled payments. One of the newest additions to the arsenal used to fight anemia in end stage renal disease patients is peginesatide Omontys , a synthetic, PEGylated, peptide based ESA that acts by stimulating the erythropoietin receptor. The role of peginesatide in the future treatment of anemia in chronic kidney disease remains uncertain, with new safety concerns being brought to attention as it emerges on the market, prompting a national recall. Hulsi Sahu | Atul Verma | Hemin Sahu "Anemia in CKD Patient on Heamodialysis" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-4 , June 2018, URL: https://www.ijtsrd.com/papers/ijtsrd14601.pd

    Sweeping has no effect on renormalized turbulent viscosity

    No full text
    We perform renormalization group analysis (RG) of the Navier-Stokes equation in the presence of constant mean velocity field U0\mathbf U_0, and show that the renormalized viscosity is unaffected by U0\mathbf U_0, thus negating the ``sweeping effect", proposed by Kraichnan [Phys. Fluids {\bf 7}, 1723 (1964)] using random Galilean invariance. Using direct numerical simulation, we show that the correlation functions u(k,t)u(k,t+τ)\langle {\mathbf u} ({\mathbf k}, t){\mathbf u}({\mathbf k}, t+\tau) \rangle for U0=0\mathbf U_0 =0 and U00\mathbf U_0 \ne 0 differ from each other, but the renormalized viscosity for the two cases are the same. Our numerical results are consistent with the RG calculations

    A Unified Shell model for Buoyancy-Driven Turbulence

    No full text
    We construct a unified shell model for stably stratified and convective turbulence. Shell model simulation of stably stratified flow in turbulent regime exhibit Bolgiano-Obukhbov (BO) scaling in which the kinetic energy spectrum varies as k11/5k^{-11/5}. However, simulation of convective turbulence shows Kolmogorov's spectrum. These results are consistent with the direct numerical simulations of Kumar {\em et al.} [Phys. Rev. E {\bf 90}, 023016 (2014)]. We also observe a dual scaling (k11/5k^{-11/5} and k5/3k^{-5/3}) for a limited range of parameters in stably stratified flow

    Energy transfers in small-scale and large-scale dynamos

    No full text
    We study energy transfers during magnetic energy growth in small-scale and large-scale dynamos. We perform direct numerical simulations for magnetic Prandtl number Pm =20 and 0.2 in a periodic box on 1024^3 grid. Energy fluxes and shell-to-shell energy transfers indicate that in small-scale dynamo for Pm =20, the magnetic energy growth takes place due to a non-local energy transfer from large-scale velocity field to small-scale magnetic field. On the other hand, in large-scale dynamo for Pm =0.2, local energy transfers from large-scale velocity field to large-scale magnetic field takes place
    corecore